or
forgot password

    • cancer clinical trials in stanford, CA

    • A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Cutaneous T-cell Lymphoma (CTCL)
    Fulvestrant in Hormone Refractory Prostate Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Prostatic Neoplasms, Prostate Cancer
    Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Multiple Myeloma
    Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Prostatic Neoplasms
    A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer
    Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer
    Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia
    A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer
    Stanford Cancer Center
    Stanford, California 94305-5824
    Breast Cancer
    Phase II Study of Bexxar in Relapsed/Refractory Diffuse Large Cell Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma
    Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
    Stanford Hospitals and Clinics
    Stanford, California 94305
    Acute Lymphoblastic Leukemia (ALL)
    Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Cutaneous T-cell Lymphoma (CTCL),
    Identification of Key Blood Molecular Markers for Immunotherapy
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Squamous Cell Carcinoma, Adenocarcinoma, Neoplasms
    BIBW 2992 (Afatinib) in Head & Neck Cancer
    1200.28.0010 Boehringer Ingelheim Investigational Site
    Stanford, California
    Head and Neck Neoplasms, Carcinoma, Squamous Cell
    Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors
    Stanford University Medical Center
    Stanford, California 94305-5408
    Advanced Solid Tumors
    Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib
    Oncology Division and General Clincial Research, Stanford University Medical Center
    Stanford, California 94305
    Carcinoma, Non-Small-Cell Lung
    A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin
    Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Anal, Colon, and Rectal Cancers, Colorectal Neoplasms, Colon/Rectal Cancer
    Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Rectal Cancer, Colon Cancer, Anal Cancer
    Healing Touch During Chemotherapy Infusions for Women With Breast Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer, Early Stage Breast Cancer (Stage 1-3)
    Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer
    Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Psoriatic Arthritis
    An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides
    Stanford University Medical Center
    Stanford, California 94305-5408
    Mycosis Fungoides
    Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Kidney Neoplasms, Carcinoma, Renal Cell, Kidney (Renal Cell) Cancer
    PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer
    Stanford Cancer Center
    Stanford, California 94305-5824
    Lung Cancer
    Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Pancreatic Cancer
    Correlation of PET-CT Studies With Serum Protein Analysis
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Carcinomas (Including Squamous Cell and Adenocarcinoma)
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    Stanford University Medical Center
    Stanford, California 94305-5408
    Multiple Sclerosis, Relapsing-Remitting
    Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Cutaneous T-cell Lymphoma
    Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedure
    Stanford University Medical Center
    Stanford, California 94305-5408
    Pneumothorax
    A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Prostate Cancer, Prostatic Neoplasms, Cancer of the Prostate
    Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Head and Neck Cancer
    QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Anal Cancer
    Evaluation of Preexisting Immunity Markers in Human Tumor Tissue Sample
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Cancer
    Pre-surgical Detection of Clear Cell Renal Cell Carcinoma Using Radiolabeled G250-Antibody
    Stanford University Medical Center
    Stanford, California 94305-5408
    Renal Cell Carcinoma, Kidney Cancer
    Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Head and Neck Cancer, Head and Neck Cancers
    Phase II Temozolomide in Acute Myeloid Leukemia Patient Age >= 60 Yrs & Poor Risk/Refractory Disease
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Leukemia, Myeloid
    Promoting Healthy Weight With 'Stability Skills First'
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Obesity
    A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis
    Stanford Comprehensive Cancer Center
    Stanford, California 94305
    Myelofibrosis
    Phase 1 Trial of Oral Ixabepilone
    Stanford University
    Stanford, California 94305
    Advanced Solid Tumors
    Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
    Stanford University Medical Center
    Stanford, California 94305-5408
    Acromegaly
    A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies
    Stanford University Medical Center
    Stanford, California 94305-5408
    Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin
    Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Kidney Neoplasms, Kidney (Renal Cell) Cancer
    Development of Vitamin D as a Therapy for Breast Cancer - Phase II
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer
    ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Metastatic Bone Tumors for the Palliation of Pain
    Stanford University Medical Center
    Stanford, California 94305-5408
    Bone Metastases, Multiple Myeloma
    Clinical and Pathologic Studies in Neuroendocrine Tumors
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Carcinoid Tumor, Neuroendocrine Tumors
    Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Colorectal Neoplasms, Colon Cancer, Rectal Cancer, Anal Cancer
    Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Stanford University
    Stanford, California 94305
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Untreated Adult Acute Myeloid Leukemia
    Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
    Stanford Cancer Center
    Stanford, California 94305-5824
    Unspecified Childhood Solid Tumor, Protocol Specific
    MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer
    Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer
    A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors
    Stanford University Dept. of Medicine-Oncology
    Stanford, California 94305
    Advanced Solid Tumors
    Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies
    Stanford Cancer Center
    Stanford, California 94305-5824
    Chronic Lymphocytic Leukemia (CLL), Lymphoma, Non-Hodgkin (NHL), Acute Myeloid Leukemia (AML), Multiple Myeloma (MM)
    Pregnancy in Polycystic Ovary Syndrome II
    Stanford University Medical Center
    Stanford, California 94305-5408
    Pregnancy, Polycystic Ovary Syndrome
    Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Head and Neck Cancers
    Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Cancer Metastatic Breast Cancer
    A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors
    Stanford University
    Stanford, California 94305
    Solid Tumors
    Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Pancreatic Cancer
    Immunobiology of Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Neoplasms
    Genetic Analysis of Liver Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Liver Cancer, Hepatitis B, Hepatitis C, Hepatobiliary Cancers, Hepatobiliary Cancers Liver
    Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Colorectal Neoplasms, Anal, Colon, and Rectal Cancers
    A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Patients With Advanced Carcinoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Advanced Carcinoma, Non-small Cell Lung Cancer
    Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
    Stanford University
    Stanford, California 94305
    Rheumatoid Arthritis
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
    Stanford University
    Stanford, California 94305
    Transfusional Hemosiderosis
    Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    B-Cell Lymphoma, B-Cell Leukemia
    Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Carcinoma, Renal Cell, Kidney Diseases, Kidney (Renal Cell) Cancer
    Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Prostatic Neoplasms
    Virtue Male Incontinence Sling Study
    Stanford University Medical Center
    Stanford, California 94305-5408
    Stress Urinary Incontinence